Allergan, Generic Cos. Debate If Tribal Patent Deal Is A 'Sham'
Generic-drug makers told a Texas federal court Friday that Allergan's transfer of patents for the dry-eye treatment Restasis to a Native American tribe in a bid to escape Patent Trial and...To view the full article, register now.
Already a subscriber? Click here to view full article